| 臺大學術典藏 |
2021-07-07T05:13:15Z |
Synthesis and biological activity of fluoro-substituted pyrrolo[2,3-d]pyrimidines: The development of potential positron emission tomography imaging agents for the corticotropin-releasing hormone type 1 receptor
|
LING-WEI HSIN; Webster E.L.; Chrousos G.P.; Gold P.W.; Eckelman W.C.; Contoreggi C.; Rice K.C. |
| 臺大學術典藏 |
2021-07-07T05:13:15Z |
Synthesis of [3H](4-fluorobutyl)propyl[2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[2,3-d]pyrimidin-4-yl]amine: A potent radioligand for corticotropin-releasing hormone type 1 receptor
|
LING-WEI HSIN; Webster E.L.; Chrousos G.P.; Gold P.W.; Eckelman W.C.; Contoreggi C.; Rice K.C. |
| 臺大學術典藏 |
2021-07-07T05:13:15Z |
Oxygenated analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1- [2- [bis (4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as potential extended-action cocaine-abuse therapeutic agents
|
Lewis D.B.; Matecka D.; Zhang Y.; LING-WEI HSIN; Dersch C.M.; Stafford D.; Glowa J.R.; Rothman R.B.; Rice K.C. |
| 臺大學術典藏 |
2021-07-07T05:13:14Z |
Development of long-acting dopamine transporter ligands as potential cocaine-abuse therapeutic agents: Chiral hydroxyl-containing derivatives of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy) ethyl]-4-(3-phenylpropyl)piperazine
|
LING-WEI HSIN; Dersch C.M.; Baumann M.H.; Stafford D.; Glowa J.R.; Rothman R.B.; Jacobson A.E.; Rice K.C. |
| 臺大學術典藏 |
2021-07-07T05:13:14Z |
The development of a potential single photon emission computed tomography (SPECT) imaging agent for the corticotropin-releasing hormone receptor type 1
|
Tian X.; LING-WEI HSIN; Webster E.L.; Contoreggi C.; Chrousos G.P.; Gold P.W.; Habib K.; Ayala A.; Eckelman W.C.; Jacobson A.E.; Rice K.C. |
| 臺大學術典藏 |
2021-07-07T05:13:14Z |
CRHR1Receptor binding and lipophilicity of pyrrolopyrimidines, potential nonpeptide corticotropin-releasing hormone type 1 receptor antagonists
|
LING-WEI HSIN; Tian X.; Webster E.L.; Coop A.; Caldwell T.M.; Jacobson A.E.; Chrousos G.P.; Gold P.W.; Habib K.E.; Ayala A.; Eckelman W.C.; Contoreggi C.; Rice K.C. |
| 臺大學術典藏 |
2021-07-07T05:13:13Z |
Synthesis and dopamine transporter affinity of chiral 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(2-hydroxypropyl)piperazines as potential cocaine abuse therapeutic agents
|
LING-WEI HSIN; Prisinzano T.; Wilkerson C.R.; Dersch C.M.; Horel R.; Jacobson A.E.; Rothman R.B.; Rice K.C. |
| 臺大學術典藏 |
2021-07-07T05:13:12Z |
A concise synthesis of (S)-(+)-1-(4-{2-[bis-(4-fluorophenyl)methoxy]-ethyl} piperazin-1-yl)-2-phenylpropan-2-ol dimaleate
|
Prisinzano T.; LING-WEI HSIN; Folk J.E.; Flippen-Anderson J.L.; George C.; Jacobson A.E.; Rice K.C. |
| 臺大學術典藏 |
2021-07-07T05:13:11Z |
The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats
|
Jutkiewicz E.M.; Wood S.K.; Houshyar H.; LING-WEI HSIN; Rice K.C.; Woods J.H. |
| 臺大學術典藏 |
2021-07-07T05:13:10Z |
Design and synthesis of 2- and 3-substituted-3-phenylpropyl analogs of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine: Role of amino, fluoro, hydroxyl, methoxyl, methyl, methylene, and oxo substituents on affinity for the dopamine and serotonin transporters
|
LING-WEI HSIN; Chang L.-T.; Rothman R.B.; Dersch C.M.; Jacobson A.E.; Rice K.C. |
| 臺大學術典藏 |
2021-07-07T05:13:09Z |
Identification of a novel "almost neutral" μ-opioid receptor antagonist in CHO cells expressing the cloned human μ-opioid receptor
|
Sally E.J.; Xu H.; Dersch C.M.; LING-WEI HSIN; Chang L.-T.; Prisinzano T.E.; Simpson D.S.; Giuvelis D.; Rice K.C.; Jacobson A.E.; Cheng K.; Bilsky E.J.; Rothman R.B. |
| 臺大學術典藏 |
2018-09-10T07:20:53Z |
Oxygenated analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1- [2- [bis (4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as potential extended-action cocaine-abuse therapeutic agents
|
Lewis, D.B.;Matecka, D.;Zhang, Y.;Hsin, L.-W.;Dersch, C.M.;Stafford, D.;Glowa, J.R.;Rothman, R.B.;Rice, K.C.; LING-WEI HSIN |
| 臺大學術典藏 |
2018-09-10T05:11:14Z |
The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats
|
Jutkiewicz, E.M.;Wood, S.K.;Houshyar, H.;Hsin, L.-W.;Rice, K.C.;Woods, J.H.; LING-WEI HSIN |
| 臺大學術典藏 |
2018-09-10T04:24:43Z |
A concise synthesis of (S)-(+)-1-(4-{2-[bis-(4-fluorophenyl)methoxy]-ethyl} piperazin-1-yl)-2-phenylpropan-2-ol dimaleate
|
Prisinzano, T.;Hsin, L.-W.;Folk, J.E.;Flippen-Anderson, J.L.;George, C.;Jacobson, A.E.;Rice, K.C.; LING-WEI HSIN |
| 臺大學術典藏 |
2018-09-10T04:24:43Z |
Synthesis and dopamine transporter affinity of chiral 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(2-hydroxypropyl)piperazines as potential cocaine abuse therapeutic agents
|
Hsin, L.-W.;Prisinzano, T.;Wilkerson, C.R.;Dersch, C.M.;Horel, R.;Jacobson, A.E.;Rothman, R.B.;Rice, K.C.; LING-WEI HSIN |
| 臺大學術典藏 |
2018-09-10T04:04:48Z |
CRHR1 Receptor binding and lipophilicity of pyrrolopyrimidines, potential nonpeptide corticotropin-releasing hormone type 1 receptor antagonists
|
Hsin, L.-W.;Tian, X.;Webster, E.L.;Coop, A.;Caldwell, T.M.;Jacobson, A.E.;Chrousos, G.P.;Gold, P.W.;Habib, K.E.;Ayala, A.;Eckelman, W.C.;Contoreggi, C.;Rice, K.C.; LING-WEI HSIN |
| 臺大學術典藏 |
2018-09-10T04:04:48Z |
Development of long-acting dopamine transporter ligands as potential cocaine-abuse therapeutic agents: Chiral hydroxyl-containing derivatives of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy) ethyl]-4-(3-phenylpropyl)piperazine
|
Hsin, L.-W.;Dersch, C.M.;Baumann, M.H.;Stafford, D.;Glowa, J.R.;Rothman, R.B.;Jacobson, A.E.;Rice, K.C.; LING-WEI HSIN |
| 臺大學術典藏 |
2018-09-10T03:41:21Z |
The development of a potential single photon emission computed tomography (SPECT) imaging agent for the corticotropin-releasing hormone receptor type 1
|
Tian, X.;Hsin, L.-W.;Webster, E.L.;Contoreggi, C.;Chrousos, G.P.;Gold, P.W.;Habib, K.;Ayala, A.;Eckelman, W.C.;Jacobson, A.E.;Rice, K.C.; LING-WEI HSIN |
| 臺大學術典藏 |
2018-09-10T03:23:36Z |
Synthesis and biological activity of fluoro-substituted pyrrolo[2,3-d]pyrimidines: The development of potential positron emission tomography imaging agents for the corticotropin-releasing hormone type 1 receptor
|
Hsin, L.-W.;Webster, E.L.;Chrousos, G.P.;Gold, P.W.;Eckelman, W.C.;Contoreggi, C.;Rice, K.C.; LING-WEI HSIN |
| 國立臺灣大學 |
2008-05 |
Design and Synthesis of 2- and 3-Substituted-3-phenylpropyl Analogs of 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(Diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine: Role of Amino, Fluoro, Hydroxyl, Meth
|
Hsin, L.-W.; Chang, L.-T.; Rothman, R. B.; Dersch, C. M.; Jacobson, A. E.; Rice, K. C. |
| 臺大學術典藏 |
2000 |
Synthesis of [3H](4-fluorobutyl)propyl[2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[2,3-d]pyrimidin-4-yl]amine: A potent radioligand for corticotropin-releasing hormone type 1 receptor
|
LING-WEI HSIN; Hsin, L.-W.;Webster, E.L.;Chrousos, G.P.;Gold, P.W.;Eckelman, W.C.;Contoreggi, C.;Rice, K.C. |
